{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:20:01Z","timestamp":1707524401669},"reference-count":9,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,9]]},"DOI":"10.7759\/cureus.20312","type":"journal-article","created":{"date-parts":[[2021,12,10]],"date-time":"2021-12-10T03:04:56Z","timestamp":1639105496000},"source":"Crossref","is-referenced-by-count":0,"title":["Heparin-Induced Renal Tubular Acidosis Masquerading as Hyperkalemia in a SARS-CoV-2 (COVID-19) Patient: A Case Report"],"prefix":"10.7759","author":[{"given":"Vidya","family":"Baleguli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riaz","family":"Mahmood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Herrera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erine","family":"Raybon-Rojas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000023430.92674.E5","article-title":"Renal tubular acidosis: the clinical entity","volume":"13","author":"Rodr\u00edguez Soriano J","year":"2002","unstructured":"Rodr\u00edguez Soriano J. Renal tubular acidosis: the clinical entity. J Am Soc Nephrol. 2002, 13:2160-70. 10.1097\/01.ASN.0000023430.92674.E5","journal-title":"J Am Soc Nephrol"},{"key":"ref2","unstructured":"National Institutes of Health. Renal tubular acidosis. (2008). https:\/\/www.niddk.nih.gov\/health-information\/kidney-disease\/renal-tubular-acidosis."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1038\/ki.1980.14","article-title":"Hyperkalemia and hyporeninemic hypoaldosteronism","volume":"17","author":"DeFronzo RA","year":"1980","unstructured":"DeFronzo RA. Hyperkalemia and hyporeninemic hypoaldosteronism. Kidney Int. 1980, 17:118-34. 10.1038\/ki.1980.14","journal-title":"Kidney Int"},{"key":"ref4","article-title":"Clinical physiology of acid-base and electrolyte disorders","author":"Rose BD","year":"2001","unstructured":"Rose BD, Post T, Post TW. Clinical physiology of acid-base and electrolyte disorders. McGraw-Hill, New York; 2001."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1097\/01.asn.0000023430.92674.e5","article-title":"Renal tubular acidosis: the clinical entity","volume":"13","author":"Rodr\u00edguez Soriano J","year":"2002","unstructured":"Rodr\u00edguez Soriano J. Renal tubular acidosis: the clinical entity. J Am Soc Nephrol. 2002, 13:2160-70. 10.1097\/01.asn.0000023430.92674.e5","journal-title":"J Am Soc Nephrol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1016\/s0002-9343(99)80017-5","article-title":"Heparin-induced aldosterone suppression and hyperkalemia","volume":"98","author":"Oster JR","year":"1995","unstructured":"Oster JR, Singer I, Fishman LM. Heparin-induced aldosterone suppression and hyperkalemia. Am J Med. 1995, 98:575-86. 10.1016\/s0002-9343(99)80017-5","journal-title":"Am J Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1159\/000167106","article-title":"Suppression of aldosterone production by low-dose heparin","volume":"6","author":"Sherman RA","year":"1986","unstructured":"Sherman RA, Ruddy MC. Suppression of aldosterone production by low-dose heparin. Am J Nephrol. 1986, 6:165-8. 10.1159\/000167106","journal-title":"Am J Nephrol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)62260-X","article-title":"Effect of low-molecular-weight heparin on serum concentrations of potassium","volume":"350","author":"Wiggam MI","year":"1997","unstructured":"Wiggam MI, Beringer TR. Effect of low-molecular-weight heparin on serum concentrations of potassium. Lancet. 1997, 350:292-3. 10.1016\/S0140-6736(05)62260-X","journal-title":"Lancet"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/pds.881","article-title":"Early onset of hyperkalemia in patients treated with low molecular weight heparin: a prospective study","volume":"13","author":"Koren-Michowitz M","year":"2004","unstructured":"Koren-Michowitz M, Avni B, Michowitz Y, Moravski G, Efrati S, Golik A. Early onset of hyperkalemia in patients treated with low molecular weight heparin: a prospective study. Pharmacoepidemiol Drug Saf. 2004, 13:299-302. 10.1002\/pds.881","journal-title":"Pharmacoepidemiol Drug Saf"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/75239-heparin-induced-renal-tubular-acidosis-masquerading-as-hyperkalemia-in-a-sars-cov-2-covid-19-patient-a-case-report","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:32:51Z","timestamp":1707507171000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/75239-heparin-induced-renal-tubular-acidosis-masquerading-as-hyperkalemia-in-a-sars-cov-2-covid-19-patient-a-case-report"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,9]]},"references-count":9,"URL":"https:\/\/doi.org\/10.7759\/cureus.20312","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,9]]}}}